The Chemours Company Statistics

Total Valuation

The Chemours Company has a market cap or net worth of MXN 58.21 billion. The enterprise value is 134.20 billion.

Market Cap	58.21B
Enterprise Value	134.20B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	Nov 15, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-0.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	148.26M

Valuation Ratios

The trailing PE ratio is 39.11.

PE Ratio	39.11
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.04, with an EV/FCF ratio of -10.15.

EV / Earnings	90.17
EV / Sales	1.14
EV / EBITDA	7.04
EV / EBIT	12.32
EV / FCF	-10.15

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 6.51.

Current Ratio	1.73
Quick Ratio	0.87
Debt / Equity	6.51
Debt / EBITDA	4.84
Debt / FCF	-6.36
Interest Coverage	1.88

Financial Efficiency

Return on equity (ROE) is 11.02% and return on invested capital (ROIC) is 6.15%.

Return on Equity (ROE)	11.02%
Return on Assets (ROA)	3.97%
Return on Invested Capital (ROIC)	6.15%
Return on Capital Employed (ROCE)	8.60%
Revenue Per Employee	18.16M
Profits Per Employee	240,046
Employee Count	6,200
Asset Turnover	0.75
Inventory Turnover	3.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.59% in the last 52 weeks. The beta is 1.75, so The Chemours Company's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-29.59%
50-Day Moving Average	397.53
200-Day Moving Average	410.21
Relative Strength Index (RSI)	11.43
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.20

Income Statement

In the last 12 months, The Chemours Company had revenue of MXN 112.58 billion and earned 1.49 billion in profits. Earnings per share was 9.84.

Revenue	112.58B
Gross Profit	22.19B
Operating Income	9.58B
Pretax Income	959.55M
Net Income	1.49B
EBITDA	15.39B
EBIT	9.58B
Earnings Per Share (EPS)	9.84

Full Income Statement

Balance Sheet

The company has 11.67 billion in cash and 84.01 billion in debt, giving a net cash position of -72.34 billion.

Cash & Cash Equivalents	11.67B
Total Debt	84.01B
Net Cash	-72.34B
Net Cash Per Share	n/a
Equity (Book Value)	12.90B
Book Value Per Share	86.12
Working Capital	25.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.66 billion and capital expenditures -7.56 billion, giving a free cash flow of -13.22 billion.

Operating Cash Flow	-5.66B
Capital Expenditures	-7.56B
Free Cash Flow	-13.22B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 19.71%, with operating and profit margins of 8.51% and 1.32%.

Gross Margin	19.71%
Operating Margin	8.51%
Pretax Margin	0.85%
Profit Margin	1.32%
EBITDA Margin	13.67%
EBIT Margin	8.51%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 18.32, which amounts to a dividend yield of 4.78%.

Dividend Per Share	18.32
Dividend Yield	4.78%
Dividend Growth (YoY)	3.79%
Years of Dividend Growth	1
Payout Ratio	196.05%
Buyback Yield	-0.41%
Shareholder Yield	4.37%
Earnings Yield	2.56%
FCF Yield	-22.71%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

The Chemours Company has an Altman Z-Score of 1.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.86
Piotroski F-Score	n/a